Triple-negative breast cancer: a new clinical study opens new and promising therapeutic prospects
The RI-MUHC will host a new Phase 3 randomized clinical trial called TROPION-Breast04, as announced today...
The 2023 RI-MUHC Annual Report is online!
An invitation from Dr. Rhian Touyz
Code Life Research Awards Ceremony
Researchers at the RI-MUHC receive support from the Montreal General Hospital Foundation and the Cedars Cancer Foundation
RI-MUHC laboratory wins the International Freezer Challenge at McGill University
This impressive win for the Specimen Processing Laboratory at the Centre for Innovation is part of a push for greater...
Record turnout for Summer Student Research Day at the RI-MUHC
This annual event gives summer students a unique opportunity to present their projects to the research community
Panel discussion at the RI-MUHC marks International Day of People Living with Disabilities
Experts and advocates joined the RI-MUHC community to discuss integrating people with disabilities into work...
Significant funding to maximize access and drive excellence in clinical trials in Quebec and Canada
RI-MUHC researchers will lead or co-lead multiple projects awarded a total of $55 million from the Canadian Institutes...
Triple-negative breast cancer: the RI-MUHC enrolls first patients in international Phase 3 clinical trial
The first participants in this large study were recently selected at the Cedars Cancer Centre of the MUHC.
The 2022 RI-MUHC Annual Report is online!
An invitation from Dr. Rhian Touyz
An Equity, Diversity and Inclusion Action Plan for the RI-MUHC
The plan prioritizes six groups traditionally underrepresented in research